Roles of p53 and p16 in triple-negative breast cancer

ISSN： 1758-1923

Source： Breast Cancer Management, Vol.2, Iss.6, 2013-11, pp. : 537-544

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Ad-p53 enhances the sensitivity of triple-negative breast cancer MDA-MB-468 cells to the EGFR inhibitor gefitinib

Oncology Reports, Vol. 33, Iss. 2, 2015-01 ,pp. : 526-532

Spandidos Publications

Access to resources Recommend Favorite

Thymoquinone, A Bioactive Component of Black Caraway Seeds, Causes G1 Phase Cell Cycle Arrest and Apoptosis in Triple-Negative Breast Cancer Cells with Mutant p53

By Sutton Kimberly M. Greenshields Anna L. Hoskin David W.

Nutrition and Cancer, Vol. 66, Iss. 3, 2014-04 ,pp. : 408-418

Routledge Ltd

Access to resources Recommend Favorite

Imaging findings of triple-negative breast cancer

By Kawashima Hiroko

Breast Cancer, Vol. 18, Iss. 3, 2011-07 ,pp. : 145-145

Springer Publishing Company

Access to resources Recommend Favorite

MR imaging of triple-negative breast cancer

By Uematsu Takayoshi

Breast Cancer, Vol. 18, Iss. 3, 2011-07 ,pp. : 161-164

Springer Publishing Company

Access to resources Recommend Favorite

The association of metabolic syndrome with triple-negative breast cancer

By Maiti B.

Breast Cancer Research and Treatment, Vol. 121, Iss. 2, 2010-06 ,pp. : 479-483

Springer Publishing Company

Access to resources Recommend Favorite